Researchers from University of California San Diego (UCSD) Report Details of New Studies and Findings in the Area of Liver Cancer (Boosted-dose Yttrium-90 Radiation Segmentectomy or Lobectomy for Hepatocellular Carcinoma Refractory To Prior...).

Předmět:
Zdroj: Hematology Week; 4/13/2023, p1150-1150, 1p
Abstrakt: Keywords: San Diego; State:California; United States; North and Central America; Angiology; Cancer; Carcinomas; Chemoembolization; Embolization; Health and Medicine; Liver Cancer; Lobectomy; Oncology; Segmentectomy; Surgery EN San Diego State:California United States North and Central America Angiology Cancer Carcinomas Chemoembolization Embolization Health and Medicine Liver Cancer Lobectomy Oncology Segmentectomy Surgery 1150 1150 1 04/10/23 20230413 NES 230413 2023 APR 11 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Investigators discuss new findings in Oncology - Liver Cancer. San Diego, State:California, United States, North and Central America, Angiology, Cancer, Carcinomas, Chemoembolization, Embolization, Health and Medicine, Liver Cancer, Lobectomy, Oncology, Segmentectomy, Surgery Keywords for this news article include: San Diego, California, United States, North and Central America, Angiology, Cancer, Carcinomas, Chemoembolization, Embolization, Health and Medicine, Liver Cancer, Lobectomy, Oncology, Segmentectomy, Surgery, University of California San Diego (UCSD). [Extracted from the article]
Databáze: Complementary Index